Related Experiment Video

Updated: Jun 8, 2026

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

Targeting miR-21 in glioma: a small RNA with big potential

Lynette M Moore1, Wei Zhang

  • 1The University of Texas M.D. Anderson Cancer Center, Department of Pathology, Houston, TX 77030, USA.

Expert Opinion on Therapeutic Targets
|October 15, 2010
PubMed
Abstract

Insights

MicroRNAs are key regulators in cancer. Targeting microRNA-21 (miR-21) in glioma offers a promising new therapeutic strategy due to its broad impact on tumor pathways, addressing limitations of current treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Current glioma therapies offer limited improvement, necessitating novel treatment strategies.
  • Targeted therapies effective in other cancers have not yet succeeded in gliomas due to pathway complexity.
  • MicroRNAs (miRNAs) are emerging as crucial regulators of cancer pathways and potential therapeutic targets.

Purpose of the Study:

  • To review the fundamental biology of microRNAs.
  • To specifically examine the role of microRNA-21 (miR-21) in glioma development and progression.
  • To explore the potential of targeting miR-21 as a therapeutic strategy for glioma.

Main Methods:

  • Literature review of microRNA biology.
  • Focused review on miR-21 function in glioma.
  • Analysis of current research on miR-21 targeted therapies.

Main Results:

  • Detailed explanation of miR-21's specific functions within glioma.
  • Overview of the current landscape of studies investigating miR-21 targeting.
  • Identification of miR-21 as a significant factor in glioma pathogenesis.

Conclusions:

  • Novel therapeutic targets are essential for advancing glioma treatment.
  • MicroRNAs represent a novel class of therapeutic targets in oncology.
  • Targeting miR-21 in glioma presents a promising strategy with potentially widespread anti-tumor effects.

More Related Videos

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...